Original from: Diasorin Diasorin (FTSE MIB: DIA) announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the LIAISON PLEX Gastrointestinal Flex Assay, a f..

Original from: Guardant Health Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360® Liq..

Original from: QIAGEN QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced at the 2026 BIO-IT World Conference & Expo in Boston that the QIAGEN Digital Insights bioinformatics business and it..

4 Blood Typing Reagents and its Technology Development Direction and Status of Market Development 4.1 Main Products and Manufacturers of Domestic Blood Typing Reagents At present, domestic blood ty..

Original from: PR Newswire AstraZeneca and Roche Diagnostics Asia Pacific today announced a three-year Memorandum of Understanding to help advance digital pathology capabilities and elevate cancer care a..

RealBio and Thermo Fisher Scientific Partner on IVD Quality Control Solutions On May 12 in Shanghai, RealBio signed a strategic agreement with Thermo Fisher Scientific to collaborate on co..

Original from: Co-Diagnostics Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic..

Original from: Natera Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved Signatera CDx as ..

Original from: PR Newswire - Labcorp's full test menu will be available through Epic's Aura platform - Integration builds on the successful deployment of Invitae genetic testing and accelerates acc..

Original from: Lucid Diagnostics Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq:..

Original from: PR Newswire Cepheid, a Danaher company, announced today that it has received CE marking under the in vitro medical device regulation (IVDR) for the Xpert GI Panel. This multiplex PCR test ..

Original from: business news - Delivers the only FDA-cleared ChLIA testosterone testing portfolio with direct measurement of total testosterone, free testosterone, and sex hormone-binding globulin ..

Original from: Waters Corporation First Quarter 2026 Highlights - Total reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformanc..

Original from: Roche Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it has received CE Mark for Elecsys® pTau217, a blood test developed in collaboration with Eli Lilly and Company and desig..

As of 30 April 2026, a total of 86 China-listed companies related to the In Vitro Diagnostics (IVD) sector had released their 2025 annual reports, including 61 companies primarily engaged in IVD businesses and 25 comp..